MedicalSentry

Health Research Company

Paroxetine Hydrochloride

generic name is paroxetine hydrochloride

Why is this drug subscribed ?

Paroxetine tablets, suspension (liquid), and extended-release (long-acting) tablets are used to treat depression, panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks), and social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life). Paroxetine tablets and suspension are also used to treat obsessive-compulsive disorder (bothersome thoughts that won't go away and the need to perform certain actions over and over), generalized anxiety disorder (GAD; excessive worrying that is difficult to control), and posttraumatic stress disorder (disturbing psychological symptoms that develop after a frightening experience). Paroxetine extended-release tablets are also used to treat premenstrual dysphoric disorder (PMDD, physical and psychological symptoms that occur before the onset of the menstrual period each month). Paroxetine is in a class of medications called selective serotonin-reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

Active Substance: PAROXETINE HYDROCHLORIDE

Paroxetine Hydrochloride Available Drugs :

Paroxetine Hydrochloride ndc# 54868-6178

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 12.5 mg/1

started marketing at 25/10/2010 .

Paroxetine Hydrochloride ndc# 54868-1819

by Physicians Total Care, Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 25 mg/1

started marketing at 23/05/2008 .

PAROXETINE HYDROCHLORIDE ndc# 63629-3327

by Bryant Ranch Prepack

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 25 mg/1

started marketing at 13/09/2010 .

Paroxetine Hydrochloride ndc# 51079-824

by Mylan Institutional Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 12.5 mg/1

started marketing at 12/09/2012 .

Paroxetine Hydrochloride ndc# 51079-825

by Mylan Institutional Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 25 mg/1

started marketing at 12/09/2012 .

PAROXETINE HYDROCHLORIDE ndc# 60505-3675

by Apotex Corp

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 37.5 mg/1

started marketing at 13/09/2010 .

PAROXETINE HYDROCHLORIDE ndc# 60505-3673

by Apotex Corp

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 12.5 mg/1

started marketing at 13/09/2010 .

PAROXETINE HYDROCHLORIDE ndc# 60505-3674

by Apotex Corp

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 25 mg/1

started marketing at 13/09/2010 .

Paroxetine Hydrochloride ndc# 49349-305

by REMEDYREPACK INC.

ORAL TABLET with active strength of 30 mg/1

started marketing at 16/06/2011 .

Paroxetine Hydrochloride ndc# 49349-364

by REMEDYREPACK INC.

ORAL TABLET with active strength of 20 mg/1

started marketing at 11/07/2011 .

Paroxetine Hydrochloride ndc# 49349-308

by REMEDYREPACK INC.

ORAL TABLET with active strength of 10 mg/1

started marketing at 17/06/2011 .

Paroxetine Hydrochloride ndc# 49349-255

by REMEDYREPACK INC.

ORAL TABLET with active strength of 20 mg/1

started marketing at 29/03/2011 .

Paroxetine Hydrochloride ndc# 49349-285

by REMEDYREPACK INC.

ORAL TABLET with active strength of 40 mg/1

started marketing at 07/06/2011 .

Paroxetine Hydrochloride ndc# 49349-407

by REMEDYREPACK INC.

ORAL TABLET with active strength of 20 mg/1

started marketing at 21/07/2011 .

Paroxetine Hydrochloride ndc# 60505-0374

by Apotex Corp.

ORAL SUSPENSION with active strength of 10 mg/5mL

started marketing at 12/12/2006 .

Paroxetine Hydrochloride ndc# 49349-610

by REMEDYREPACK INC.

ORAL TABLET with active strength of 10 mg/1

started marketing at 03/11/2011 .

Paroxetine Hydrochloride ndc# 0378-2005

by Mylan Pharmaceuticals Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 37.5 mg/1

started marketing at 26/08/2011 .

Paroxetine Hydrochloride ndc# 0378-2003

by Mylan Pharmaceuticals Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 12.5 mg/1

started marketing at 26/08/2011 .

Paroxetine Hydrochloride ndc# 0378-2004

by Mylan Pharmaceuticals Inc.

ORAL TABLET, FILM COATED, EXTENDED RELEASE with active strength of 25 mg/1

started marketing at 26/08/2011 .

Paroxetine Hydrochloride Search Trends:

News :

Social Buzz

comments powered by Disqus